DNA methylation can provide an alternative target in the search for biomarkers that could provide a sensitive, specific, and early marker for cancer diagnosis and prognosis [22, 23]. SHISA3 is a newly found TSG in non-small-cell lung cancer, which conducts its tumor suppression activity through the Wnt signaling pathway [15]. This evidence concerns the gene SHISA3 and neoplasm.